Here's How Much You Would Have Made Owning Krystal Biotech Stock In The Last 5 Years
Portfolio Pulse from Benzinga Insights
Krystal Biotech (NASDAQ:KRYS) has significantly outperformed the market over the past 5 years, delivering an average annual return of 34.64%. A $100 investment in KRYS 5 years ago would now be worth $426.51. The company's current market capitalization is $5.82 billion.
July 22, 2024 | 2:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Krystal Biotech has delivered an impressive average annual return of 34.64% over the past 5 years, significantly outperforming the market. A $100 investment 5 years ago would now be worth $426.51.
The article highlights Krystal Biotech's strong performance over the past 5 years, which is likely to positively influence investor sentiment and potentially drive the stock price higher in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100